HMR:NASDAQHeidmar Maritime Holdings Corp. Analysis
Data as of 2026-05-21 - not real-time
$1.23
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Heidmar Maritime (HMR) is trading at $1.23, well below its DCF‑derived fair value of $6.71, suggesting an implied upside of over 100% (upside/downside pct: 103.3%). Technicals show a bullish MACD (macd_signal: bullish) but an extreme RSI of 80.6, flagging short‑term overbought conditions. The price sits near the upper end of its recent range (resistance $1.2899) with a solid support zone at $0.73, and volume is trending higher, indicating growing market interest.
Fundamentally, the company reports negative operating margins and a -40% profit margin, with a high debt‑to‑equity ratio (≈382) and a recent fleet expansion of five crude tankers. The upcoming Q1 earnings call (May 26) and the recent Nasdaq notice add near‑term uncertainty. Overall, the stock appears deeply undervalued but carries considerable earnings volatility and balance‑sheet risk.
Fundamentally, the company reports negative operating margins and a -40% profit margin, with a high debt‑to‑equity ratio (≈382) and a recent fleet expansion of five crude tankers. The upcoming Q1 earnings call (May 26) and the recent Nasdaq notice add near‑term uncertainty. Overall, the stock appears deeply undervalued but carries considerable earnings volatility and balance‑sheet risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI > 80 indicating overbought pressure
- Price near resistance at $1.2899
- Upcoming earnings release adds near‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests >100% upside
- Increasing volume and recent fleet expansion
- Bullish MACD and neutral trend direction
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Fundamental undervaluation relative to industry PE
- Long‑term demand for tanker and bulk shipping services
- Potential for balance‑sheet improvement through cash flow generation
Key Metrics & Analysis
Financial Health
Revenue Growth371.90%
Profit Margin-40.39%
P/E Ratio4.9
ROE-59.72%
ROA-5.60%
Debt/Equity381.89
P/B Ratio6.7
Op. Cash Flow$12.3M
Free Cash Flow$11.9M
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI80.6
Support$0.73
Resistance$1.29
MA 20$0.89
MA 50$0.86
MA 200$1.08
MACDBullish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair Value$6.71
Target Price$2.50
Upside/Downside103.25%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.77
Volatility74.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.